正科医药 (836342.OC)

+ 收藏

财务摘要(报告期)(正科医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.450.340.320.490.24
 每股收益 - 稀释(元) 0.450.340.320.49-
 每股收益 - 期末股本摊薄(元) 0.450.340.320.490.24
 每股净资产BPS(元) 2.201.731.911.741.84
 每股经营活动产生的现金流量净额(元) 0.540.540.210.610.22
 每股营业收入(元) 1.792.441.312.451.33
关键比率:
 净资产收益率 - 摊薄(%) 20.5819.7618.9531.9213.21
 净资产收益率 - 加权(%) -21.1917.0629.5814.14
 净资产收益率 - 平均(%) 23.0319.6719.9131.2014.14
 净资产收益率 - 扣除(%) -19.2518.8433.3612.56
 总资产净利率 - 平均(%) 15.9613.3612.3519.7310.03
 总资产报酬率ROA(%) 16.6712.6013.3722.4211.00
 投入资本回报率ROIC(%) 19.8316.8015.4525.5712.09
 销售毛利率(%) 74.6065.0769.2572.1977.24
 销售净利率(%) 25.1914.0024.4119.9518.27
 资产负债率(%) 31.5529.5435.1540.8626.02
 资产周转率(倍) 0.630.950.510.990.55
 销售商品提供劳务收到的现金/营业收入(%) 96.85109.9793.34114.45102.00
 营业利润同比增长率(%) 37.62-41.9130.37478.47502.84
 营业收入同比增长率(%) 36.52-0.29-1.45-2.4119.98
 利润总额同比增长率(%) 37.16-41.6430.61474.04511.14
 归属母公司股东的净利润同比增长率(%) 40.88-34.6631.705,202.84537.30
 扣非后归属母公司股东的净利润同比增长率(%) --29.9737.711,662.58617.57
 总资产同比增长率(%) 22.91-7.694.729.376.19
 总负债同比增长率(%) 10.32-20.8041.4638.38-7.41
 净资产同比增长率(%) 29.7413.04-8.217.6011.98
利润表摘要:
 营业总收入(元) 130,594,078.24177,617,692.2795,660,587.63178,127,819.9597,065,404.40
 营业总成本(元) 95,779,744.83156,528,873.0169,603,608.69138,713,974.2178,760,225.48
 营业收入(元) 130,594,078.24177,617,692.2795,660,587.63178,127,819.9597,065,404.40
 营业利润(元) 34,079,325.8022,320,390.8224,762,906.1739,475,897.0518,994,797.28
 利润总额(元) 33,948,592.9922,366,020.5824,751,720.5139,372,612.4818,951,471.17
 净利润(元) 32,897,039.3724,864,516.3123,351,627.0135,537,246.7517,730,536.15
 归属母公司股东的净利润(元) 32,897,039.3724,864,516.3123,351,627.0135,537,246.7517,730,536.15
 非经常性损益(元) -642,854.79152,360.07918,976.29872,783.63
 归属母公司股东的净利润扣除非经常性损益(元) -24,221,661.5223,214,219.2337,132,866.5216,857,752.52
资产负债表摘要:
 流动资产(元) 91,975,682.5449,547,223.8067,533,764.1872,819,492.0462,713,411.67
 固定资产(元) 63,360,746.8062,718,321.9261,746,933.7761,594,669.7157,847,304.37
 资产总计(元) 233,576,010.53178,619,981.94190,032,298.54188,215,450.82181,468,705.38
 流动负债(元) 72,035,746.2050,178,641.5463,603,938.7872,914,598.6042,689,591.94
 非流动负债(元) 1,664,194.722,581,998.933,201,596.343,983,753.814,534,517.27
 负债合计(元) 73,699,940.9252,760,640.4766,805,535.1276,898,352.4147,224,109.21
 股东权益(元) 159,876,069.61125,859,341.47123,226,763.42111,317,098.41134,244,596.17
 归属母公司股东的权益(元) 159,876,069.61125,859,341.47123,226,763.42111,317,098.41134,244,596.17
 资本公积(元) 30,465,222.5929,345,533.8228,225,845.0728,039,230.2728,039,230.27
 盈余公积(元) 11,741,049.0211,741,049.029,731,836.849,731,836.845,227,406.57
 未分配利润(元) 44,851,598.0011,954,558.6312,450,881.51727,831.3028,159,759.33
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 126,483,202.30195,332,764.7389,291,277.19203,859,915.1999,005,738.98
 经营活动产生的现金净流量(元) 39,161,548.7839,109,800.9415,031,456.5844,724,975.7216,034,414.00
 购建固定无形长期资产支付的现金(元) 24,535,060.2430,982,336.7015,880,896.0719,382,947.849,444,172.28
 投资支付的现金(元) 27,200,000.0043,800,000.0014,000,000.00126,600,000.0067,500,000.00
 投资活动产生的现金净流量(元) -33,885,255.61-20,724,463.39-9,220,406.02-17,411,159.37-12,579,588.67
 取得借款收到的现金(元) 25,500,000.0066,415,000.0047,415,000.0069,030,000.0031,050,000.00
 筹资活动产生的现金净流量(元) 285,373.65-20,784,997.88-1,558,853.57-23,010,758.37-3,325,441.25
 现金及现金等价物净增加(元) 5,561,666.82-2,399,660.334,252,196.994,303,057.98129,384.08
 期末现金及现金等价物余额(元) 10,712,567.155,150,900.3311,802,757.657,550,560.663,376,886.76
 折旧与摊销(元) -17,400,430.228,313,666.6112,909,089.086,746,022.42
公告日期 2024-08-282024-04-252023-08-282023-04-282022-08-25
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院